Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-12

FDA Approved: ELMIRON — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Janssen's supplemental application for Elmiron (pentosan polysulfate sodium), updating its labeling and approved indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elmiron (pentosan polysulfate sodium)

Snippet

SUPPL AP for ELMIRON (PENTOSAN POLYSULFATE SODIUM)